Tachypnea, hypoventilation, and respiratory depression are more frequent in cases of obesity and seem to be attenuated by long-term leptin administration.[71,72] These findings suggest that leptin may be a modulator of central respiration. The gene discussed is LEP; the disease is respiratory depression.